According to MarketsandMarkets™, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%.

We reviewed the options for the manufacture and use of DNA microarrays in the original Chipping Forecast 1 in 1999. Since then, the number of companies that produce microarrays equipment and reagents ...

According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...

PS, designed entirely by artificial intelligence, passed its first human safety trial at Cambridge — triggering ...

As genetic testing becomes increasingly important in modern healthcare, cytogenetics is emerging as a promising career for ...

DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading ...

Scientists have now traced why the H5N1 bird flu virus that jumped into U.S. dairy herds keeps turning up in cows’ udders and ...

Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...

Raphas, a mass-production platform company specializing in microneedle technology, has teamed up with Japanese electronics ...

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that studies featuring optical genome mapping (OGM) at the 2026 European Society of Human Genetics (ESHG) ...

Expensive stocks typically earn their valuations through superior growth rates that other companies simply can’t match. The ...